<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2020-10-07" version="232">
<accession>P01111</accession>
<accession>Q14971</accession>
<accession>Q15104</accession>
<accession>Q15282</accession>
<name>RASN_HUMAN</name>
<protein>
<recommendedName>
<fullName>GTPase NRas</fullName>
<ecNumber evidence="5">3.6.5.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Transforming protein N-Ras</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NRAS</name>
<name type="synonym">HRAS1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1983" name="Cell" volume="34" first="581" last="586">
<title>Structure and activation of the human N-ras gene.</title>
<authorList>
<person name="Taparowsky E."/>
<person name="Shimizu K."/>
<person name="Goldfarb M."/>
<person name="Wigler M."/>
</authorList>
<dbReference type="PubMed" id="6616621"/>
<dbReference type="DOI" id="10.1016/0092-8674(83)90390-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1985" name="Nucleic Acids Res." volume="13" first="5255" last="5268">
<title>Human N-ras: cDNA cloning and gene structure.</title>
<authorList>
<person name="Hall A."/>
<person name="Brown R."/>
</authorList>
<dbReference type="PubMed" id="2991860"/>
<dbReference type="DOI" id="10.1093/nar/13.14.5255"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1984" name="EMBO J." volume="3" first="1321" last="1326">
<title>Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080.</title>
<authorList>
<person name="Brown R."/>
<person name="Marshall C.J."/>
<person name="Pennie S.G."/>
<person name="Hall A."/>
</authorList>
<dbReference type="PubMed" id="6086315"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1984.tb01970.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Fibrosarcoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1984" name="Proc. Natl. Acad. Sci. U.S.A." volume="81" first="3670" last="3674">
<title>Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells.</title>
<authorList>
<person name="Yuasa Y."/>
<person name="Gol R.A."/>
<person name="Chang A."/>
<person name="Chiu I.-M."/>
<person name="Reddy E.P."/>
<person name="Tronick S.R."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="6587382"/>
<dbReference type="DOI" id="10.1073/pnas.81.12.3670"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Lung carcinoma</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2002-03" db="EMBL/GenBank/DDBJ databases">
<title>cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org).</title>
<authorList>
<person name="Puhl H.L. III"/>
<person name="Ikeda S.R."/>
<person name="Aronstam R.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2003-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1985" name="Blood" volume="66" first="1371" last="1378">
<title>Transforming genes in human leukemia cells.</title>
<authorList>
<person name="Hirai H."/>
<person name="Tanaka S."/>
<person name="Azuma M."/>
<person name="Anraku Y."/>
<person name="Kobayashi Y."/>
<person name="Fujisawa M."/>
<person name="Okabe T."/>
<person name="Urabe A."/>
<person name="Takaku F."/>
</authorList>
<dbReference type="PubMed" id="2998510"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE OF 1-96</scope>
<scope>VARIANT CYS-12</scope>
<source>
<tissue>Leukemia</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1990" name="Oncogene" volume="5" first="589" last="596">
<title>Transforming genes from familial adenomatous polyposis patient cells detected by a tumorigenicity assay.</title>
<authorList>
<person name="Yuasa Y."/>
<person name="Kamiyama T."/>
<person name="Kato M."/>
<person name="Iwama T."/>
<person name="Ikeuchi T."/>
<person name="Tonomura A."/>
</authorList>
<dbReference type="PubMed" id="1970154"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE OF 1-29 AND 43-78</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="879" last="882">
<title>Activation of an N-ras gene in acute myeloblastic leukemia through somatic mutation in the first exon.</title>
<authorList>
<person name="Gambke C."/>
<person name="Hall A."/>
<person name="Moroni C."/>
</authorList>
<dbReference type="PubMed" id="3856237"/>
<dbReference type="DOI" id="10.1073/pnas.82.3.879"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 38-96</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1987" name="Nature" volume="327" first="430" last="432">
<title>A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.</title>
<authorList>
<person name="Hirai H."/>
<person name="Kobayashi Y."/>
<person name="Mano H."/>
<person name="Hagiwara K."/>
<person name="Maru Y."/>
<person name="Omine M."/>
<person name="Mizoguchi H."/>
<person name="Nishida J."/>
<person name="Takaku F."/>
</authorList>
<dbReference type="PubMed" id="3295562"/>
<dbReference type="DOI" id="10.1038/327430a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 38-96</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="1988" name="Cancer Res." volume="48" first="950" last="953">
<title>Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay.</title>
<authorList>
<person name="Raybaud F."/>
<person name="Noguchi T."/>
<person name="Marics I."/>
<person name="Adelaide J."/>
<person name="Planche J."/>
<person name="Batoz M."/>
<person name="Aubet C."/>
<person name="de Lapeyriere O."/>
<person name="Birnbaum D."/>
</authorList>
<dbReference type="PubMed" id="3276402"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 60-96</scope>
<scope>VARIANT ARG-61</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1989" name="Cell" volume="57" first="1167" last="1177">
<title>All ras proteins are polyisoprenylated but only some are palmitoylated.</title>
<authorList>
<person name="Hancock J.F."/>
<person name="Magee A.I."/>
<person name="Childs J.E."/>
<person name="Marshall C.J."/>
</authorList>
<dbReference type="PubMed" id="2661017"/>
<dbReference type="DOI" id="10.1016/0092-8674(89)90054-8"/>
</citation>
<scope>PALMITOYLATION AT CYS-181</scope>
<scope>ISOPRENYLATION AT CYS-186</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="2318" last="2326">
<title>RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.</title>
<authorList>
<person name="Nikiforova M.N."/>
<person name="Lynch R.A."/>
<person name="Biddinger P.W."/>
<person name="Alexander E.K."/>
<person name="Dorn G.W. II"/>
<person name="Tallini G."/>
<person name="Kroll T.G."/>
<person name="Nikiforov Y.E."/>
</authorList>
<dbReference type="PubMed" id="12727991"/>
<dbReference type="DOI" id="10.1210/jc.2002-021907"/>
</citation>
<scope>INVOLVEMENT IN NMTC2</scope>
<scope>VARIANT NMTC2 ARG-61</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="31141" last="31148">
<title>DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H- and N-Ras.</title>
<authorList>
<person name="Swarthout J.T."/>
<person name="Lobo S."/>
<person name="Farh L."/>
<person name="Croke M.R."/>
<person name="Greentree W.K."/>
<person name="Deschenes R.J."/>
<person name="Linder M.E."/>
</authorList>
<dbReference type="PubMed" id="16000296"/>
<dbReference type="DOI" id="10.1074/jbc.m504113200"/>
</citation>
<scope>PALMITOYLATION AT CYS-181</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Science" volume="307" first="1746" last="1752">
<title>An acylation cycle regulates localization and activity of palmitoylated Ras isoforms.</title>
<authorList>
<person name="Rocks O."/>
<person name="Peyker A."/>
<person name="Kahms M."/>
<person name="Verveer P.J."/>
<person name="Koerner C."/>
<person name="Lumbierres M."/>
<person name="Kuhlmann J."/>
<person name="Waldmann H."/>
<person name="Wittinghofer A."/>
<person name="Bastiaens P.I.H."/>
</authorList>
<dbReference type="PubMed" id="15705808"/>
<dbReference type="DOI" id="10.1126/science.1105654"/>
</citation>
<scope>PALMITOYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="FEBS Lett." volume="583" first="3133" last="3139">
<title>Distinct kinetics of (H/K/N)Ras glucosylation and Rac1 glucosylation catalysed by Clostridium sordellii lethal toxin.</title>
<authorList>
<person name="Huelsenbeck S.C."/>
<person name="Klose I."/>
<person name="Reichenbach M."/>
<person name="Huelsenbeck J."/>
<person name="Genth H."/>
</authorList>
<dbReference type="PubMed" id="19744486"/>
<dbReference type="DOI" id="10.1016/j.febslet.2009.09.006"/>
</citation>
<scope>GLYCOSYLATION AT THR-35 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="Cell Death Differ." volume="18" first="645" last="655">
<title>RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting the activity of phosphorylated-MKK7.</title>
<authorList>
<person name="Takahashi S."/>
<person name="Ebihara A."/>
<person name="Kajiho H."/>
<person name="Kontani K."/>
<person name="Nishina H."/>
<person name="Katada T."/>
</authorList>
<dbReference type="PubMed" id="21278800"/>
<dbReference type="DOI" id="10.1038/cdd.2010.137"/>
</citation>
<scope>INTERACTION WITH RASSF7</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2015" name="Elife" volume="4" first="E11306" last="E11306">
<title>ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization.</title>
<authorList>
<person name="Lin D.T."/>
<person name="Conibear E."/>
</authorList>
<dbReference type="PubMed" id="26701913"/>
<dbReference type="DOI" id="10.7554/elife.11306"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PALMITOYLATION AT CYS-181</scope>
<scope>MUTAGENESIS OF CYS-181</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2018" name="Science" volume="362" first="1177" last="1182">
<title>Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination.</title>
<authorList>
<person name="Steklov M."/>
<person name="Pandolfi S."/>
<person name="Baietti M.F."/>
<person name="Batiuk A."/>
<person name="Carai P."/>
<person name="Najm P."/>
<person name="Zhang M."/>
<person name="Jang H."/>
<person name="Renzi F."/>
<person name="Cai Y."/>
<person name="Abbasi Asbagh L."/>
<person name="Pastor T."/>
<person name="De Troyer M."/>
<person name="Simicek M."/>
<person name="Radaelli E."/>
<person name="Brems H."/>
<person name="Legius E."/>
<person name="Tavernier J."/>
<person name="Gevaert K."/>
<person name="Impens F."/>
<person name="Messiaen L."/>
<person name="Nussinov R."/>
<person name="Heymans S."/>
<person name="Eyckerman S."/>
<person name="Sablina A.A."/>
</authorList>
<dbReference type="PubMed" id="30442762"/>
<dbReference type="DOI" id="10.1126/science.aap7607"/>
</citation>
<scope>UBIQUITINATION AT LYS-170</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2019" name="Cell" volume="176" first="1113" last="1127">
<title>Pharmacological targeting of STK19 inhibits oncogenic NRAS-driven melanomagenesis.</title>
<authorList>
<person name="Yin C."/>
<person name="Zhu B."/>
<person name="Zhang T."/>
<person name="Liu T."/>
<person name="Chen S."/>
<person name="Liu Y."/>
<person name="Li X."/>
<person name="Miao X."/>
<person name="Li S."/>
<person name="Mi X."/>
<person name="Zhang J."/>
<person name="Li L."/>
<person name="Wei G."/>
<person name="Xu Z.X."/>
<person name="Gao X."/>
<person name="Huang C."/>
<person name="Wei Z."/>
<person name="Goding C.R."/>
<person name="Wang P."/>
<person name="Deng X."/>
<person name="Cui R."/>
</authorList>
<dbReference type="PubMed" id="30712867"/>
<dbReference type="DOI" id="10.1016/j.cell.2019.01.002"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-89</scope>
<scope>MUTAGENESIS OF SER-89</scope>
<scope>VARIANT ARG-61</scope>
<scope>CHARACTERIZATION OF VARIANT ARG-61</scope>
</reference>
<reference key="24">
<citation type="submission" date="2008-03" db="PDB data bank">
<title>Crystal structure of the human NRAS GTPase bound with GDP.</title>
<authorList>
<person name="Nedyalkova L."/>
<person name="Tong Y."/>
<person name="Tempel W."/>
<person name="Shen L."/>
<person name="Loppnau P."/>
<person name="Arrowsmith C.H."/>
<person name="Edwards A.M."/>
<person name="Bountra C."/>
<person name="Weigelt J."/>
<person name="Bochkarev A."/>
<person name="Park H."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 1-172 IN COMPLEX WITH GDP</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1987" name="Jpn. J. Cancer Res." volume="78" first="21" last="26">
<title>Amino-acid substitution at codon 13 of the N-ras oncogene in rectal cancer in a Japanese patient.</title>
<authorList>
<person name="Nitta N."/>
<person name="Ochiai M."/>
<person name="Nagao M."/>
<person name="Sugimura T."/>
</authorList>
<dbReference type="PubMed" id="3102434"/>
</citation>
<scope>VARIANT COLORECTAL CANCER ARG-13</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="Blood" volume="109" first="5477" last="5480">
<title>Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations.</title>
<authorList>
<person name="Matsuda K."/>
<person name="Shimada A."/>
<person name="Yoshida N."/>
<person name="Ogawa A."/>
<person name="Watanabe A."/>
<person name="Yajima S."/>
<person name="Iizuka S."/>
<person name="Koike K."/>
<person name="Yanai F."/>
<person name="Kawasaki K."/>
<person name="Yanagimachi M."/>
<person name="Kikuchi A."/>
<person name="Ohtsuka Y."/>
<person name="Hidaka E."/>
<person name="Yamauchi K."/>
<person name="Tanaka M."/>
<person name="Yanagisawa R."/>
<person name="Nakazawa Y."/>
<person name="Shiohara M."/>
<person name="Manabe A."/>
<person name="Kojima S."/>
<person name="Koike K."/>
</authorList>
<dbReference type="PubMed" id="17332249"/>
<dbReference type="DOI" id="10.1182/blood-2006-09-046649"/>
</citation>
<scope>VARIANTS JMML ASP-12 AND ASP-13</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="8953" last="8958">
<title>NRAS mutation causes a human autoimmune lymphoproliferative syndrome.</title>
<authorList>
<person name="Oliveira J.B."/>
<person name="Bidere N."/>
<person name="Niemela J.E."/>
<person name="Zheng L."/>
<person name="Sakai K."/>
<person name="Nix C.P."/>
<person name="Danner R.L."/>
<person name="Barb J."/>
<person name="Munson P.J."/>
<person name="Puck J.M."/>
<person name="Dale J."/>
<person name="Straus S.E."/>
<person name="Fleisher T.A."/>
<person name="Lenardo M.J."/>
</authorList>
<dbReference type="PubMed" id="17517660"/>
<dbReference type="DOI" id="10.1073/pnas.0702975104"/>
</citation>
<scope>VARIANT RALD ASP-13</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="J. Invest. Dermatol." volume="129" first="139" last="147">
<title>Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis.</title>
<authorList>
<person name="Dessars B."/>
<person name="De Raeve L.E."/>
<person name="Morandini R."/>
<person name="Lefort A."/>
<person name="El Housni H."/>
<person name="Ghanem G.E."/>
<person name="Van den Eynde B.J."/>
<person name="Ma W."/>
<person name="Roseeuw D."/>
<person name="Vassart G."/>
<person name="Libert F."/>
<person name="Heimann P."/>
</authorList>
<dbReference type="PubMed" id="18633438"/>
<dbReference type="DOI" id="10.1038/jid.2008.203"/>
</citation>
<scope>VARIANTS CMNS ARG-13 AND ARG-61</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Nat. Genet." volume="42" first="27" last="29">
<title>A restricted spectrum of NRAS mutations causes Noonan syndrome.</title>
<authorList>
<person name="Cirstea I.C."/>
<person name="Kutsche K."/>
<person name="Dvorsky R."/>
<person name="Gremer L."/>
<person name="Carta C."/>
<person name="Horn D."/>
<person name="Roberts A.E."/>
<person name="Lepri F."/>
<person name="Merbitz-Zahradnik T."/>
<person name="Konig R."/>
<person name="Kratz C.P."/>
<person name="Pantaleoni F."/>
<person name="Dentici M.L."/>
<person name="Joshi V.A."/>
<person name="Kucherlapati R.S."/>
<person name="Mazzanti L."/>
<person name="Mundlos S."/>
<person name="Patton M.A."/>
<person name="Silengo M.C."/>
<person name="Rossi C."/>
<person name="Zampino G."/>
<person name="Digilio C."/>
<person name="Stuppia L."/>
<person name="Seemanova E."/>
<person name="Pennacchio L.A."/>
<person name="Gelb B.D."/>
<person name="Dallapiccola B."/>
<person name="Wittinghofer A."/>
<person name="Ahmadian M.R."/>
<person name="Tartaglia M."/>
<person name="Zenker M."/>
</authorList>
<dbReference type="PubMed" id="19966803"/>
<dbReference type="DOI" id="10.1038/ng.497"/>
</citation>
<scope>VARIANTS NS6 ILE-50 AND GLU-60</scope>
<scope>CHARACTERIZATION OF VARIANTS NS6 ILE-50 AND GLU-60</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="J. Med. Genet." volume="49" first="249" last="253">
<title>Keratinocytic epidermal nevi are associated with mosaic RAS mutations.</title>
<authorList>
<person name="Hafner C."/>
<person name="Toll A."/>
<person name="Gantner S."/>
<person name="Mauerer A."/>
<person name="Lurkin I."/>
<person name="Acquadro F."/>
<person name="Fernandez-Casado A."/>
<person name="Zwarthoff E.C."/>
<person name="Dietmaier W."/>
<person name="Baselga E."/>
<person name="Parera E."/>
<person name="Vicente A."/>
<person name="Casanova A."/>
<person name="Cigudosa J."/>
<person name="Mentzel T."/>
<person name="Pujol R.M."/>
<person name="Landthaler M."/>
<person name="Real F.X."/>
</authorList>
<dbReference type="PubMed" id="22499344"/>
<dbReference type="DOI" id="10.1136/jmedgenet-2011-100637"/>
</citation>
<scope>VARIANTS KNEN ASP-12; LEU-34 AND ARG-61</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="J. Invest. Dermatol." volume="133" first="2229" last="2236">
<title>Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.</title>
<authorList>
<person name="Kinsler V.A."/>
<person name="Thomas A.C."/>
<person name="Ishida M."/>
<person name="Bulstrode N.W."/>
<person name="Loughlin S."/>
<person name="Hing S."/>
<person name="Chalker J."/>
<person name="McKenzie K."/>
<person name="Abu-Amero S."/>
<person name="Slater O."/>
<person name="Chanudet E."/>
<person name="Palmer R."/>
<person name="Morrogh D."/>
<person name="Stanier P."/>
<person name="Healy E."/>
<person name="Sebire N.J."/>
<person name="Moore G.E."/>
</authorList>
<dbReference type="PubMed" id="23392294"/>
<dbReference type="DOI" id="10.1038/jid.2013.70"/>
</citation>
<scope>VARIANTS CMNS ARG-61 AND LYS-61</scope>
<scope>VARIANTS NCMS ARG-61 AND LYS-61</scope>
</reference>
<comment type="function">
<text evidence="22">Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>GTP + H2O = GDP + H(+) + phosphate</text>
<dbReference type="Rhea" id="RHEA:19669"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:37565"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:58189"/>
<dbReference type="EC" id="3.6.5.2"/>
</reaction>
</comment>
<comment type="activity regulation">
<text>Alternates between an inactive form bound to GDP and an active form bound to GTP. Activated by a guanine nucleotide-exchange factor (GEF) and inactivated by a GTPase-activating protein (GAP).</text>
</comment>
<comment type="subunit">
<text evidence="6 16">Interacts (active GTP-bound form preferentially) with RGS14 (By similarity). Interacts (active GTP-bound form) with RASSF7 (PubMed:21278800).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-721993">
<id>P01111</id>
</interactant>
<interactant intactId="EBI-9383168">
<id>Q96II5</id>
<label>ARAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-721993">
<id>P01111</id>
</interactant>
<interactant intactId="EBI-365980">
<id>P15056</id>
<label>BRAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-721993">
<id>P01111</id>
</interactant>
<interactant intactId="EBI-365996">
<id>P04049</id>
<label>RAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-721993">
<id>P01111</id>
</interactant>
<interactant intactId="EBI-12832744">
<id>P52306-5</id>
<label>RAP1GDS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-721993">
<id>P01111</id>
</interactant>
<interactant intactId="EBI-2856274">
<id>Q3MIN7</id>
<label>RGL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-721993">
<id>P01111</id>
</interactant>
<interactant intactId="EBI-366017">
<id>Q13671</id>
<label>RIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-721993">
<id>P01111</id>
</interactant>
<interactant intactId="EBI-2584830">
<id>P28028</id>
<label>Braf</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-721993">
<id>P01111</id>
</interactant>
<interactant intactId="EBI-397757">
<id>Q99N57</id>
<label>Raf1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="9 20">Cell membrane</location>
<topology evidence="9 20">Lipid-anchor</topology>
<orientation evidence="9 20">Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 20">Golgi apparatus membrane</location>
<topology evidence="9 20">Lipid-anchor</topology>
</subcellularLocation>
<text evidence="9 20">Shuttles between the plasma membrane and the Golgi apparatus.</text>
</comment>
<comment type="PTM">
<text evidence="9 10 19 20">Palmitoylated by the ZDHHC9-GOLGA7 complex (PubMed:16000296). Depalmitoylated by ABHD17A, ABHD17B and ABHD17C (PubMed:26701913). A continuous cycle of de- and re-palmitoylation regulates rapid exchange between plasma membrane and Golgi (PubMed:16000296, PubMed:15705808, PubMed:2661017, PubMed:26701913).</text>
</comment>
<comment type="PTM">
<text evidence="5">Acetylation at Lys-104 prevents interaction with guanine nucleotide exchange factors (GEFs).</text>
</comment>
<comment type="PTM">
<text evidence="27">Ubiquitinated by the BCR(LZTR1) E3 ubiquitin ligase complex at Lys-170 in a non-degradative manner, leading to inhibit Ras signaling by decreasing Ras association with membranes.</text>
</comment>
<comment type="PTM">
<text evidence="22">Phosphorylation at Ser-89 by STK19 enhances NRAS-association with its downstream effectors.</text>
</comment>
<comment type="PTM">
<text evidence="14">(Microbial infection) Glucosylated at Thr-35 by P.sordellii toxin TcsL.</text>
</comment>
<comment type="disease" evidence="11">
<disease id="DI-01851">
<name>Leukemia, juvenile myelomonocytic</name>
<acronym>JMML</acronym>
<description>An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages.</description>
<dbReference type="MIM" id="607785"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="15">
<disease id="DI-02558">
<name>Noonan syndrome 6</name>
<acronym>NS6</acronym>
<description>A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells.</description>
<dbReference type="MIM" id="613224"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="12">
<disease id="DI-03381">
<name>RAS-associated autoimmune leukoproliferative disorder</name>
<acronym>RALD</acronym>
<description>A disorder of apoptosis, characterized by chronic accumulation of non-malignant lymphocytes, defective lymphocyte apoptosis, and an increased risk for the development of hematologic malignancies.</description>
<dbReference type="MIM" id="614470"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="13 18">
<disease id="DI-04099">
<name>Melanocytic nevus syndrome, congenital</name>
<acronym>CMNS</acronym>
<description>A syndrome characterized by congenital pigmentary skin lesions which can occur at any site and can cover most of the body surface. These lesions may or may not be hairy. Congenital melanocytic nevi are associated with neuromelanosis (the presence of melanin-producing cells within the brain parenchyma or leptomeninges). Less commonly they are associated with malignant melanoma in childhood, both in the skin and the central nervous system. CMNS patients also tend to have a characteristic facial appearance, including wide or prominent forehead, periorbital fullness, small short nose with narrow nasal bridge, round face, full cheeks, prominent premaxilla, and everted lower lip.</description>
<dbReference type="MIM" id="137550"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="18">
<disease id="DI-04100">
<name>Melanosis, neurocutaneous</name>
<acronym>NCMS</acronym>
<description>A rare congenital disease characterized by the presence of giant or multiple melanocytic nevi on the skin, foci of melanin-producing cells within the brain parenchyma, and infiltration of leptomeninges by abnormal melanin deposits. Neurologic abnormalities include seizures, hydrocephalus, arachnoid cysts, tumors, and syringomyelia. Some patients may develop malignant melanoma.</description>
<dbReference type="MIM" id="249400"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="17">
<disease id="DI-01860">
<name>Keratinocytic non-epidermolytic nevus</name>
<acronym>KNEN</acronym>
<description>Epidermal nevi of the common, non-organoid and non-epidermolytic type are benign skin lesions and may vary in their extent from a single (usually linear) lesion to widespread and systematized involvement. They may be present at birth or develop early during childhood.</description>
<dbReference type="MIM" id="162900"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="8">
<disease id="DI-04532">
<name>Thyroid cancer, non-medullary, 2</name>
<acronym>NMTC2</acronym>
<description>A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms.</description>
<dbReference type="MIM" id="188470"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Mutations which change AA 12, 13 or 61 activate the potential of Ras to transform cultured cells and are implicated in a variety of human tumors.</text>
</comment>
<comment type="similarity">
<text evidence="26">Belongs to the small GTPase superfamily. Ras family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/NRASID92.html"/>
</comment>
<comment type="online information" name="NRASbase">
<link uri="http://structure.bmc.lu.se/idbase/NRASbase/"/>
<text>NRAS mutation db</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/nras/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/RAS_proteins"/>
<text>RAS proteins entry</text>
</comment>
<dbReference type="EC" id="3.6.5.2" evidence="5"/>
<dbReference type="EMBL" id="X02751">
<property type="protein sequence ID" value="CAA26529.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X00642">
<property type="protein sequence ID" value="CAA25269.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X00643">
<property type="protein sequence ID" value="CAA25270.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X00644">
<property type="protein sequence ID" value="CAA25271.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X00645">
<property type="protein sequence ID" value="CAA25272.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00043">
<property type="protein sequence ID" value="AAA60255.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00040">
<property type="protein sequence ID" value="AAA60255.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00041">
<property type="protein sequence ID" value="AAA60255.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00042">
<property type="protein sequence ID" value="AAA60255.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF493919">
<property type="protein sequence ID" value="AAM12633.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY428630">
<property type="protein sequence ID" value="AAQ94397.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC005219">
<property type="protein sequence ID" value="AAH05219.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M25898">
<property type="protein sequence ID" value="AAA36548.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X53291">
<property type="protein sequence ID" value="CAA37384.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X53292">
<property type="protein sequence ID" value="CAA37384.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="K03211">
<property type="protein sequence ID" value="AAA36556.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M10055">
<property type="protein sequence ID" value="AAA36556.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X05565">
<property type="protein sequence ID" value="CAA29079.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X07440">
<property type="protein sequence ID" value="CAA30320.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS877.1"/>
<dbReference type="PIR" id="A90839">
<property type="entry name" value="TVHURA"/>
</dbReference>
<dbReference type="PIR" id="I38149">
<property type="entry name" value="I38149"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002515.1">
<property type="nucleotide sequence ID" value="NM_002524.4"/>
</dbReference>
<dbReference type="PDB" id="2N9C">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-17"/>
</dbReference>
<dbReference type="PDB" id="3CON">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=1-172"/>
</dbReference>
<dbReference type="PDB" id="5UHV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.67"/>
<property type="chains" value="A=1-166"/>
</dbReference>
<dbReference type="PDB" id="6E6H">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.99"/>
<property type="chains" value="A=1-166"/>
</dbReference>
<dbReference type="PDB" id="6MPP">
<property type="method" value="NMR"/>
<property type="chains" value="B=55-64"/>
</dbReference>
<dbReference type="PDB" id="6ULI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.88"/>
<property type="chains" value="C=10-18"/>
</dbReference>
<dbReference type="PDB" id="6ULK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="C=10-19"/>
</dbReference>
<dbReference type="PDB" id="6ULN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="C=10-18"/>
</dbReference>
<dbReference type="PDB" id="6ULR">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="C=10-18"/>
</dbReference>
<dbReference type="PDB" id="6UON">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="C/F=10-19"/>
</dbReference>
<dbReference type="PDB" id="6WGH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B=1-170"/>
</dbReference>
<dbReference type="PDBsum" id="2N9C"/>
<dbReference type="PDBsum" id="3CON"/>
<dbReference type="PDBsum" id="5UHV"/>
<dbReference type="PDBsum" id="6E6H"/>
<dbReference type="PDBsum" id="6MPP"/>
<dbReference type="PDBsum" id="6ULI"/>
<dbReference type="PDBsum" id="6ULK"/>
<dbReference type="PDBsum" id="6ULN"/>
<dbReference type="PDBsum" id="6ULR"/>
<dbReference type="PDBsum" id="6UON"/>
<dbReference type="PDBsum" id="6WGH"/>
<dbReference type="SMR" id="P01111"/>
<dbReference type="BioGRID" id="110952">
<property type="interactions" value="629"/>
</dbReference>
<dbReference type="DIP" id="DIP-1058N"/>
<dbReference type="ELM" id="P01111"/>
<dbReference type="IntAct" id="P01111">
<property type="interactions" value="61"/>
</dbReference>
<dbReference type="MINT" id="P01111"/>
<dbReference type="STRING" id="9606.ENSP00000358548"/>
<dbReference type="BindingDB" id="P01111"/>
<dbReference type="ChEMBL" id="CHEMBL2079845"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2823"/>
<dbReference type="iPTMnet" id="P01111"/>
<dbReference type="MetOSite" id="P01111"/>
<dbReference type="PhosphoSitePlus" id="P01111"/>
<dbReference type="SwissPalm" id="P01111"/>
<dbReference type="BioMuta" id="NRAS"/>
<dbReference type="DMDM" id="131883"/>
<dbReference type="OGP" id="P01111"/>
<dbReference type="CPTAC" id="CPTAC-1549"/>
<dbReference type="EPD" id="P01111"/>
<dbReference type="jPOST" id="P01111"/>
<dbReference type="MassIVE" id="P01111"/>
<dbReference type="PaxDb" id="P01111"/>
<dbReference type="PeptideAtlas" id="P01111"/>
<dbReference type="PRIDE" id="P01111"/>
<dbReference type="ProteomicsDB" id="51320"/>
<dbReference type="Antibodypedia" id="4118">
<property type="antibodies" value="550 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4893"/>
<dbReference type="Ensembl" id="ENST00000369535">
<property type="protein sequence ID" value="ENSP00000358548"/>
<property type="gene ID" value="ENSG00000213281"/>
</dbReference>
<dbReference type="GeneID" id="4893"/>
<dbReference type="KEGG" id="hsa:4893"/>
<dbReference type="CTD" id="4893"/>
<dbReference type="DisGeNET" id="4893"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000213281.4"/>
<dbReference type="GeneCards" id="NRAS"/>
<dbReference type="GeneReviews" id="NRAS"/>
<dbReference type="HGNC" id="HGNC:7989">
<property type="gene designation" value="NRAS"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000213281">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="NRAS"/>
<dbReference type="MIM" id="137550">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="162900">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="164790">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="188470">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="249400">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607785">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613224">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614470">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P01111"/>
<dbReference type="OpenTargets" id="ENSG00000213281"/>
<dbReference type="Orphanet" id="146">
<property type="disease" value="Differentiated thyroid carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="86834">
<property type="disease" value="Juvenile myelomonocytic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="626">
<property type="disease" value="Large congenital melanocytic nevus"/>
</dbReference>
<dbReference type="Orphanet" id="2612">
<property type="disease" value="Linear nevus sebaceus syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="411533">
<property type="disease" value="NON RARE IN EUROPE: Melanoma"/>
</dbReference>
<dbReference type="Orphanet" id="648">
<property type="disease" value="Noonan syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="268114">
<property type="disease" value="RAS-associated autoimmune leukoproliferative disease"/>
</dbReference>
<dbReference type="Orphanet" id="357194">
<property type="disease" value="Selection of therapeutic option in colorectal cancer"/>
</dbReference>
<dbReference type="Orphanet" id="544260">
<property type="disease" value="Selection of therapeutic option in melanoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31768"/>
<dbReference type="eggNOG" id="KOG0395">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000158947"/>
<dbReference type="HOGENOM" id="CLU_041217_9_8_1"/>
<dbReference type="InParanoid" id="P01111"/>
<dbReference type="KO" id="K07828"/>
<dbReference type="OMA" id="RIPCKLM"/>
<dbReference type="OrthoDB" id="1259506at2759"/>
<dbReference type="PhylomeDB" id="P01111"/>
<dbReference type="TreeFam" id="TF312796"/>
<dbReference type="PathwayCommons" id="P01111"/>
<dbReference type="Reactome" id="R-HSA-112412">
<property type="pathway name" value="SOS-mediated signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1169092">
<property type="pathway name" value="Activation of RAS in B cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236382">
<property type="pathway name" value="Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250196">
<property type="pathway name" value="SHC1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250347">
<property type="pathway name" value="SHC1 events in ERBB4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433557">
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167044">
<property type="pathway name" value="Signalling to RAS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-171007">
<property type="pathway name" value="p38MAPK events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-179812">
<property type="pathway name" value="GRB2 events in EGFR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180336">
<property type="pathway name" value="SHC1 events in EGFR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186763">
<property type="pathway name" value="Downstream signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963640">
<property type="pathway name" value="GRB2 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210993">
<property type="pathway name" value="Tie2 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2179392">
<property type="pathway name" value="EGFR Transactivation by Gastrin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2424491">
<property type="pathway name" value="DAP12 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2428933">
<property type="pathway name" value="SHC-related events triggered by IGF1R"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871796">
<property type="pathway name" value="FCERI mediated MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-375165">
<property type="pathway name" value="NCAM signaling for neurite out-growth"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-442982">
<property type="pathway name" value="Ras activation upon Ca2+ influx through NMDA receptor"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218921">
<property type="pathway name" value="VEGFR2 mediated cell proliferation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621575">
<property type="pathway name" value="CD209 (DC-SIGN) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5637810">
<property type="pathway name" value="Constitutive Signaling by EGFRvIII"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654688">
<property type="pathway name" value="SHC-mediated cascade:FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654693">
<property type="pathway name" value="FRS-mediated FGFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654699">
<property type="pathway name" value="SHC-mediated cascade:FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654700">
<property type="pathway name" value="FRS-mediated FGFR2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654704">
<property type="pathway name" value="SHC-mediated cascade:FGFR3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654706">
<property type="pathway name" value="FRS-mediated FGFR3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654712">
<property type="pathway name" value="FRS-mediated FGFR4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654719">
<property type="pathway name" value="SHC-mediated cascade:FGFR4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655253">
<property type="pathway name" value="Signaling by FGFR2 in disease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655291">
<property type="pathway name" value="Signaling by FGFR4 in disease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655302">
<property type="pathway name" value="Signaling by FGFR1 in disease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5658442">
<property type="pathway name" value="Regulation of RAS by GAPs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673000">
<property type="pathway name" value="RAF activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674135">
<property type="pathway name" value="MAP2K and MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5675221">
<property type="pathway name" value="Negative regulation of MAPK pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802946">
<property type="pathway name" value="Signaling by moderate kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802948">
<property type="pathway name" value="Signaling by high-kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802952">
<property type="pathway name" value="Signaling by BRAF and RAF fusions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802953">
<property type="pathway name" value="RAS signaling downstream of NF1 loss-of-function variants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802955">
<property type="pathway name" value="Paradoxical activation of RAF signaling by kinase inactive BRAF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-74751">
<property type="pathway name" value="Insulin receptor signalling cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849471">
<property type="pathway name" value="PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8851805">
<property type="pathway name" value="MET activates RAS signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853334">
<property type="pathway name" value="Signaling by FGFR3 fusions in cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853338">
<property type="pathway name" value="Signaling by FGFR3 point mutants in cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9026519">
<property type="pathway name" value="Activated NTRK2 signals through RAS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9027284">
<property type="pathway name" value="Erythropoietin activates RAS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9028731">
<property type="pathway name" value="Activated NTRK2 signals through FRS2 and FRS3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9034864">
<property type="pathway name" value="Activated NTRK3 signals through RAS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9607240">
<property type="pathway name" value="FLT3 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9634285">
<property type="pathway name" value="Constitutive Signaling by Overexpressed ERBB2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9634635">
<property type="pathway name" value="Estrogen-stimulated signaling through PRKCZ"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9649913">
<property type="pathway name" value="RAS GTPase cycle mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9649948">
<property type="pathway name" value="Signaling downstream of RAS mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9664565">
<property type="pathway name" value="Signaling by ERBB2 KD Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9665348">
<property type="pathway name" value="Signaling by ERBB2 ECD mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9665686">
<property type="pathway name" value="Signaling by ERBB2 TMD/JMD mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9673767">
<property type="pathway name" value="Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9673770">
<property type="pathway name" value="Signaling by PDGFRA extracellular domain mutants"/>
</dbReference>
<dbReference type="SignaLink" id="P01111"/>
<dbReference type="SIGNOR" id="P01111"/>
<dbReference type="BioGRID-ORCS" id="4893">
<property type="hits" value="61 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="NRAS">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P01111"/>
<dbReference type="GeneWiki" id="Neuroblastoma_RAS_viral_oncogene_homolog"/>
<dbReference type="GenomeRNAi" id="4893"/>
<dbReference type="Pharos" id="P01111">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P01111"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P01111">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000213281">
<property type="expression patterns" value="Expressed in testis and 233 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P01111">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P01111">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070821">
<property type="term" value="C:tertiary granule membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019003">
<property type="term" value="F:GDP binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005525">
<property type="term" value="F:GTP binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003924">
<property type="term" value="F:GTPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001938">
<property type="term" value="P:positive regulation of endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007265">
<property type="term" value="P:Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR005225">
<property type="entry name" value="Small_GTP-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001806">
<property type="entry name" value="Small_GTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR020849">
<property type="entry name" value="Small_GTPase_Ras-type"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24070">
<property type="entry name" value="PTHR24070"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00071">
<property type="entry name" value="Ras"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00231">
<property type="entry name" value="small_GTP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51421">
<property type="entry name" value="RAS"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0342">GTP-binding</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0636">Prenylation</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="GTPase NRas" id="PRO_0000043006">
<location>
<begin position="1"/>
<end position="186"/>
</location>
</feature>
<feature type="propeptide" description="Removed in mature form" id="PRO_0000043007" evidence="4">
<location>
<begin position="187"/>
<end position="189"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="GTP" evidence="25">
<location>
<begin position="10"/>
<end position="18"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="GTP" evidence="25">
<location>
<begin position="29"/>
<end position="30"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="GTP" evidence="7">
<location>
<begin position="57"/>
<end position="61"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="GTP" evidence="25">
<location>
<begin position="116"/>
<end position="119"/>
</location>
</feature>
<feature type="region of interest" description="Hypervariable region">
<location>
<begin position="166"/>
<end position="185"/>
</location>
</feature>
<feature type="short sequence motif" description="Effector region">
<location>
<begin position="32"/>
<end position="40"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by STK19" evidence="22">
<location>
<position position="89"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="10 19 20">
<location>
<position position="181"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-farnesyl cysteine" evidence="19">
<location>
<position position="186"/>
</location>
</feature>
<feature type="glycosylation site" description="(Microbial infection) O-linked (Glc) threonine; by P.sordellii toxin TcsL" evidence="14">
<location>
<position position="35"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="27">
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In leukemia; dbSNP:rs121913250." id="VAR_021194" evidence="21">
<original>G</original>
<variation>C</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In KNEN and JMML; dbSNP:rs121913237." id="VAR_071129" evidence="11 17">
<original>G</original>
<variation>D</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In RALD and JMML; dbSNP:rs121434596." id="VAR_063084" evidence="11 12">
<original>G</original>
<variation>D</variation>
<location>
<position position="13"/>
</location>
</feature>
<feature type="sequence variant" description="In CMNS and colorectal cancer; somatic mutation; dbSNP:rs121434595." id="VAR_006845" evidence="13 23">
<original>G</original>
<variation>R</variation>
<location>
<position position="13"/>
</location>
</feature>
<feature type="sequence variant" description="In KNEN; dbSNP:rs397514553." id="VAR_071130" evidence="17">
<original>P</original>
<variation>L</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In NS6; hypermorphic mutation; dbSNP:rs267606921." id="VAR_063085" evidence="15">
<original>T</original>
<variation>I</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In NS6; hypermorphic mutation; dbSNP:rs267606920." id="VAR_063086" evidence="15">
<original>G</original>
<variation>E</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In CMNS and NCMS; somatic mutation; dbSNP:rs121913254." id="VAR_006846" evidence="18">
<original>Q</original>
<variation>K</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In CMNS, NCMS, KNEN and NMTC2; also found in lung carcinoma cell and melanoma; impaired GTP hydrolysis activity, trapping NRAS in a constitutive GTP-bound active conformation; promotes melanomagenesis; dbSNP:rs11554290." id="VAR_006847" evidence="8 13 17 18 22 24">
<original>Q</original>
<variation>R</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished phosphorylation by STK19." evidence="22">
<original>S</original>
<variation>A</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of GTP-binding activity.">
<original>R</original>
<variation>A</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of plasma membrane localization." evidence="20">
<original>C</original>
<variation>S</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2"/>
<end position="9"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="16"/>
<end position="25"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="38"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="49"/>
<end position="57"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="62"/>
<end position="64"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="66"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="76"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="87"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="111"/>
<end position="116"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="127"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="152"/>
<end position="166"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3CON"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UHV"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6WGH"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P01116"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q04970"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12727991"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15705808"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16000296"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17332249"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17517660"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18633438"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19744486"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19966803"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21278800"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22499344"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23392294"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2661017"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26701913"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2998510"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30712867"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3102434"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3276402"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="24"/>
</evidence>
<evidence key="26" type="ECO:0000305"/>
<evidence key="27" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="30442762"/>
</source>
</evidence>
<sequence length="189" mass="21229" checksum="6898D3F6815B1EC7" modified="1986-07-21" version="1" precursor="true">MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKCDLPTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQYRMKKLNSSDDGTQGCMGLPCVVM</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

